Insight

8
Sep, 2025
How Innovation is Turning the Tide in the Costly Fight Against Antimicrobial Resistance
Taxis Pharmaceuticals|September 8th, 2025|TAXIS Blog|
A century ago, antibiotics transformed medicine. What were once deadly infections suddenly became curable, ushering in an era where surgery, childbirth, and even everyday cuts carried far less risk. Unfortunately, that medical miracle is now under threat. Across the world, doctors and healthcare systems are [...]

$2.9 Million NIH Grant for Novel Investigational Therapeutic to Combat Antibiotic-Resistant Gonorrhea
May 27th, 2025News Releases
TAXIS has received a $2.9 million grant to further advance R&D efforts for its dihydrofolate reductase inhibitors (DHFRIs) as a novel approach to combat multi-drug resistant gonorrhea, a rapidly spreading deadly and highly resistant strain of Neisseria gonorrhoeae.
Innovative Approaches to Antibiotic Resistance: The Promise of TXA709
December 17th, 2024TAXIS Blog
Understanding the mechanisms behind antibiotic resistance reveals the pressing need for innovative solutions in the pharmaceutical landscape. Presenting TAXIS Pharmaceuticals' Commitment to Innovation: TXA709. TAXIS is dedicated to developing novel therapies that specifically target resistant strains of bacteria.
Antimicrobial Resistance (AMR) White Paper
November 18th, 2024TAXIS Blog
Our new white paper delves into the global scope of AMR, shedding light on its widespread impact and the variability of its effects across different regions. The paper outlines actionable strategies to combat AMR, such as enhancing global surveillance systems, advocating for responsible antibiotic use, investing in the development of innovative treatments, and fostering international collaboration.

14
Oct, 2024
Contagion Live: Funding Isn’t Everything: Bringing Pharma to the Table for the Pasteur Act
Greg Mario|October 14th, 2024|Media Coverage|
The prospective bill, the Pasteur Act, is one potential strategy to help in these areas, and incentivize pharmaceutical companies to develop these essential therapies. This article was originally published on contagionlive.com.
16
Jul, 2025
Genetic Engineering & Biotechnology News: The Antimicrobial Resistance Crisis
Taxis Pharmaceuticals|July 16th, 2025|Media Coverage|
This article was originally published in Genetic Engineering & Biotechnology News under the title of The Antimicrobial Resistance Crisis Eradicating a Global Health Threat
10
Oct, 2024
Podcast interview, CareTalk: Healthcare. Unfiltered. Reversing the Rapid Rise of Antibiotic Resistance
Taxis Pharmaceuticals|October 10th, 2024|Media Coverage|
Reversing the Rapid Rise of Antibiotic Resistance. Greg Mario joins David E. Williams to discuss the real and potentially imminent dangers of antibiotic-resistant infections and the new technologies being developed to combat this growing threat.

Ready to talk?